Trial reportBMC psychiatry2024
Mixed-Mode Mindfulness-based cognitive therapy for psychological resilience, Self Esteem and Stigma of patients with schizophrenia: a randomized controlled trial.
Trial report in BMC psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Effectiveness of Cognitive Behavioral Therapies Targeting Cognitive Biases and Beliefs in Schizophrenia-Spectrum Disorders: A Systematic Review and Meta-Analysis.Schizophrenia bulletin · 2026Pooled it
- Effects of mindfulness-based interventions on insight and stigma in patients with schizophrenia: a systematic review and meta-analysis.Frontiers in psychiatry · 2025Pooled it
- Investigating the effect of eye movement desensitization and reprocessing on internalized stigma in patients with major depressive disorder: a randomized controlled trial.BMC psychiatry · 2026Trial
- Effectiveness and Cost-Effectiveness of an App-Based Mindfulness Breast Care Program for Reducing Body Image Distress and Stigma Among Survivors of Breast Cancer: Randomized Controlled Trial.Journal of medical Internet research · 2026Trial
- An empirical study of offline and online group metacognitive training in patients with schizophrenia.BMC psychiatry · 2025Trial
- Disentangling Anhedonia and Self-Stigma in Schizophrenia Using Bayesian Network Analysis.Alpha psychiatry · 2026Article
- Article
- Metabolic profiling reveals potential biomarkers and underlying signaling pathways involved in mindfulness-based cognitive therapy-improved adolescent depression symptoms.EXCLI journal · 2026Article
- Self-esteem and inner strengths: a network study in Thai university students with borderline personality disorder symptoms.Frontiers in psychiatry · 2026Article
- The Moderating Role of Social Functioning in the Relationship Between Stigma and Quality of Life in Rural Chinese Patients with Schizophrenia: A Cross-Sectional Study.Neuropsychiatric disease and treatment · 2026Article
- Hope-Enhancing Interventions in Schizophrenia Survivors: A Snyder's Hope Theory-Based Scoping Review.Journal of multidisciplinary healthcare · 2026Review
- Effect of a logotherapy-based psychoeducational program on interpersonal guilt, self-efficacy, and resilience in patients with schizophrenia: a quasi-experimental study.BMC psychiatry · 2025Article
- Latent profile analysis of emotional inhibition in older adults with gastrointestinal tumors: A cross-sectional study.Asia-Pacific journal of oncology nursing · 2025Article
- Effects of Long-Term Institutionalization on the Linguistic-Communicative Performance of Patients with Schizophrenia.Healthcare (Basel, Switzerland) · 2025Article
- The Mediating Role of Internalized Stigma and Illness Knowledge in the Relationship Between Psychological Flexibility and Symptom Severity in Schizophrenia.The Psychiatric quarterly · 2025Article
- Mental health literacy and the stigmatisation and discrimination of individuals affected by mental illnesses in China: a scoping review.The Lancet regional health. Western Pacific · 2025Review
- Association between self-stigma and self-compassion in patients with schizophrenia: A longitudinal study from hospital admission to first follow-up after discharge.Japan journal of nursing science : JJNS · 2025Article
- Integrating psychological resilience into community health strategies: addressing stigma-induced social alienation in postoperative colorectal cancer patients.Frontiers in public health · 2025Article
- Understanding Resilience in Parents: Longitudinal Examination of Trait Resilience, Stressful Life Events, and Psychological Distress Symptoms-Insights From the FinnBrain Study.Stress and health : journal of the International Society for the Investigation of Stress · 2024Article
- Unveiling the interoception impairment in various major depressive disorder stages.CNS neuroscience & therapeutics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPeople with schizophrenia often face challenges such as lower psychological resilience, reduced self-worth, and increased social stigma, hindering their recovery. Mindfulness-Based Cognitive Therapy (MBCT) has shown promise in boosting psychological resilience and self-esteem while diminishing stigma. However, MBCT demands professional involvement and substantial expenses, adding to the workload of professionals and the financial strain on patients. Mixed-mode Mindfulness-Based Cognitive Therapy (M-MBCT) integrates both "face-to-face" and "self-help" approaches to minimize staff effort and costs. This study aims to assess the impact of M-MBCT on the psychological resilience, self-esteem, and stigma in schizophrenia patients.
methodsThis randomized, controlled, parallel-group, assessor-blinded clinical trial enrolled 174 inpatients with schizophrenia. Participants were randomly assigned to either the experimental or control group. The experimental group underwent an 8-week M-MBCT intervention, while the control group received standard treatment. Data collection employed the Connor-Davidson Resilience Scale (CD-RISC), Internalized Stigma of Mental Illness Scale (ISMI), and Rosenberg Self-Esteem Scale (RSES) before and after the intervention. Post-intervention, significant differences in ISMI, CD-RISC, and RSES scores were observed between the experimental and control groups.
resultsIn the experimental group, ISMI scores notably decreased, while CD-RISC and RSES scores significantly increased (P < 0.05). Multiple linear regression analysis identified age, education, and family history of mental illness as significant factors related to stigma (P < 0.05). Additionally, correlation analysis indicated a significant negative relationship between the reduction in CD-RISC scores and the reduction in ISMI scores (P < 0.05).
conclusionM-MBCT effectively enhanced psychological resilience and self-esteem while diminishing stigma in individuals with schizophrenia. M-MBCT emerges as a promising treatment option for schizophrenia sufferers.
trial registrationThe trial was registered at the Chinese Clinical Trial Registry on 03/06/2023 ( www.chictr.org.cn ; ChiCTR ID: ChiCTR2300069071).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.